Evidence map›Paper›PMID 39682196›Full record

ReviewCancers2024

Diabetes Mellitus and Prostate Cancer Risk-A Systematic Review and Meta-Analysis.

Agnieszka Drab, Krystian Wdowiak, Wiesław Kanadys, Krzysztof Zajączkowski, Paweł Koczkodaj, Urszula Religioni, Mariola Borowska, Magdalena Łoś, Macarena Lozano-Lorca

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Diabetes and cancer: glucose control impact on survival and tumor outcomes.Reviews in endocrine & metabolic disorders · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Agnieszka DrabChair of Preclinical Sciences, Department of Medical Informatics and Statistics, Medical University of Lublin, 20-090 Lublin, Poland.ORCID 0000-0002-4864-0184
Krystian WdowiakFaculty of Medicine, Medical University of Lublin, K. Jaczewskiego 5 Street, 20-090 Lublin, Poland.ORCID 0000-0001-6579-3695
Wiesław KanadysFaculty of Medicine, Medical University of Lublin, K. Jaczewskiego 5 Street, 20-090 Lublin, Poland.
Krzysztof ZajączkowskiDepartment of Urology, Center of Oncology of the Lublin Region St. Jana z Dukli, 20-091 Lublin, Poland.
Paweł KoczkodajDepartment of Cancer Epidemiology and Primary Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.ORCID 0000-0002-7525-0181
Urszula ReligioniSchool of Public Health, Centre of Postgraduate Medical Education of Warsaw, 00-041 Warsaw, Poland.ORCID 0000-0002-1434-2138
Mariola BorowskaDepartment of Cancer Epidemiology and Primary Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.ORCID 0000-0002-6129-2356
Magdalena ŁośDepartment of Social Medicine and Public Health, Warsaw Medical University, 02-007 Warsaw, Poland.
Macarena Lozano-LorcaDepartamento de Medicina Preventiva y Salud Pública, Universidad de Granada, 18071 Granada, Spain.ORCID 0000-0001-5282-814X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionProstate cancer is the second most commonly diagnosed malignant tumor worldwide and poses a significant challenge to public health. This systematic review and meta-analysis aims to investigate the association between diabetes mellitus and the risk of developing prostate cancer.

methodsWe conducted a search of PubMed, Embase, and the Cochrane Library from 1998 to 2024. The risk of bias within the included studies was assessed using the Newcastle-Ottawa Scale. The DerSimonian-Laird random-effect model was employed for the meta-analysis. Heterogeneity was evaluated using a forest plot and statistically assessed via the Q test, I

resultsForty-three studies involving a total of 3,746,769 patients were included. Both case-control (pOR = 0.68, 95% CI: 0.61-0.97; I

conclusionsOur meta-analysis of recent observational studies indicates that diabetes mellitus is associated with a reduced risk of developing prostate cancer.

Indexed as

diabetes mellitusmeta-analysisprostate cancer

Identifiers

PMID39682196
PMCPMC11640538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.